BioPharma Dive 13. Apr. 2026 Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma
BioPharma Dive 8. Apr. 2026 Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure